Fig. 7From: A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinomaCorrelation between the risk score and antitumor drug sensitivity. The correlation of the risk score with antitumor drug sensitivity, including a negative correlation with bexarotene (A), cisplatin (B), epothilone B (C), GSK-650394 (D), OSU-03012 (E) and pyrimethamine (F), and a positive correlation with phenformin (G) and KIN001-135 (H)Back to article page